Determinants of activity and efficacy of anti-PD1/PD-L1 therapy in patients with advanced solid tumors recruited in a clinical trials unit: a longitudinal prospective biomarker-based study

Javier Garciá Corbacho, Francesco Schettini, Azucena E. González Navarro et al.|Cancer Immunology Immunotherapy|2023

Cited by 19